Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151435 · ClinicalTrials.gov registry record
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 43
- Enrollment target
NCT02151435 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 43 participants.
The verdict
NCT02151435 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal, fibrotic disorder of the lung. The estimated prevalence is 30-80/100,000 in the United States with incidence estimates clearly rising. A major challenge in the care of patients with IPF is determining prognosis. The natural history of IPF is usually one of inexorable decline in lung function, ultimately resulting in death from respiratory failure. However, longitudinal physiologic decline in IPF is heterogeneous and difficult to predict in individual patients. While some patients with IPF may remain stable for years, in others the disease may progress rapidly over a relatively short time. We hypothesize that peripheral blood biomarkers based on extracellular matrix and matrix-modifying molecules will improve prognostication in patients with IPF.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02151435
The ClinicalTrials.gov registry entry for NCT02151435 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02151435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02151435 about?
NCT02151435 is a clinical study titled "Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis". Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal, fibrotic disorder of the lung. The estimated prevalence is 30-80/100,000 in the United States with incidence estimates clearly rising. A major challenge in the care of patients with IPF is determining prognosis. The natural history of IPF ...
What is the current status of trial NCT02151435?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2013-08. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT02151435?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.